m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
Jinkushal Industries Ltd IPO Day 2 Subscription Status

Jinkushal Industries Ltd

IPO Day 2 Subscription Status

Jinkushal Industries Ltd IPO Day 2 Subscription Status

Jinkushal Industries Ltd IPO Day 2 Subscriptions Status: Check Bidding Details

Summary of IPO:

Jinkushal Industries Ltd IPO consists of an offer for sale of 11.61 shares and a fresh issue of ₹104.54. The IPO’s price band is ₹115 – ₹121 per share. The company’s shares will be listed on BSE, NSE on 03 Oct 25

The initial public offering of Jinkushal Industries Ltd ended the second day with investors bidding 3.43 times the available shares. The retail investor portion of the IPO was subscribed 5.0073 times the available shares on offer. Retail investors have 3,359,842 / 6,721,048 (49.99%) shares of the total issue reserved for them.

At the end of bidding on day 2, the qualified institutional buyers 56,760 / 23,069,040 (0.25%) portion of the IPO got bids for 0.0295 times the available shares on offer. The QIB portion includes insurance companies, domestic mutual funds, foreign institutional buyers, and other institutional investors.

The non institutional investors quota got bids for 4.2978 times the available quota of shares. This segment includes HNI and ultra HNI investors.

Here are the key details of Jinkushal Industries Ltd IPO

Offer for sale: 11.61 shares 

Fresh issue: 104.54 

Price Band: ₹115 – ₹ 121 per share 

Bid open dates: 25 Sep 25 

Allotment date: 30 Sep 25 

Listing date: 03 Oct 25

More Related Articles

Symbiotec Pharmalab IPO: Date, price, lot size, everything you need to know

Symbiotec Pharmalab IPO: Date, price, lot size, everything you need to know

Calendar graphicAugust 25, 2026 | 0 mins read

Symbiotec Pharmalab is a biopharmaceutical and biotechnology business that develops and manufactures active pharmaceutical ingredients, or APIs, and intermediates. The company has a strong presence in corticosteroids and steroidal hormone APIs, which are used in a range of pharmaceutical formulations. Its product portfolio also includes biotechnology-based ingredients, vitamins, minerals and nutraceutical ingredients for pharmaceutical, nutrition and wellness applications.

Read More

Augmont Enterprises Ltd

IPO Day 3 Subscription Status

Augmont Enterprises Ltd IPO Day 3 Subscription Status

Augmont Enterprises Ltd IPO Day 3 Subscription Status

Calendar graphicAugust 25, 2026 | 0 mins read

Augmont Enterprises Ltd is launching its IPO on 21 Aug 26. Check here the Day 3 IPO subscription status on m.Stock.

Read More

Symbiotec Pharmalab Ltd

IPO Day 2 Subscription Status

Symbiotec Pharmalab Ltd IPO Day 2 Subscription Status

Symbiotec Pharmalab Ltd IPO Day 2 Subscription Status

Calendar graphicAugust 25, 2026 | 0 mins read

Symbiotec Pharmalab Ltd is launching its IPO on 24 Aug 26. Check here the Day 2 IPO subscription status on m.Stock.

Read More
View All